Abstract

Background

Moral injury affects a variety of populations who make ethically complex decisions involving their own and others’ well-being, including combat veterans, healthcare workers, and first responders. Yet little is known about occupational differences in the prevalence of morally injurious exposures and outcomes in nationally representative samples of such populations.

Objective

To examine prevalence of potentially morally injurious event (PMIE) exposure and clinically meaningful moral injury in three high-risk groups.

Design

Cross-sectional survey with responses weighted to national geodemographic benchmarks.

Participants

Combat veterans, healthcare workers, and first responders (N=1232) in the USA.

Main Measure

Moral Injury and Distress Scale (MIDS).

Key Results

Many combat veterans (49.3%), healthcare workers (50.8%), and first responders (41.6%) endorsed exposure to a PMIE. Clinically meaningful moral injury symptoms were endorsed by 6.5% of combat veterans, 7.3% of healthcare workers, and 4.1% of first responders. After adjusting for age, gender, race, and ethnicity, relative to first responders, combat veterans were more likely to endorse transgressing their values by what they did and healthcare workers were more likely to endorse witnessing others’ wrongful acts. Additionally, combat veterans (adjusted risk ratio (aRR) = 2.18, 95% confidence interval (95% CI) = 1.09, 2.16) and healthcare workers (aRR = 2.02, 95% CI = 1.03, 3.83) were over twice as likely to screen positive for clinically meaningful moral injury in comparison to first responders. No differences in exposures or outcomes emerged between combat veterans and healthcare workers.

Conclusions

Results from these nationally representative samples of three high-risk populations suggest that exposure to PMIEs is common and a sizable minority report clinically meaningful moral injury.

Topic

JGIM

Author Descriptions

Mental Health Service, San Francisco VA Health Care System, San Francisco, USA
Shira Maguen PhD

Department of Psychiatry and Behavioral Sciences, University of California San Francisco School of Medicine, San Francisco, USA
Shira Maguen PhD

Center for Mental Health Care & Outcomes Research, Central Arkansas VA, North Little Rock, USA
Brandon J. Griffin PhD

Psychiatric Research Institute, University of Arkansas for Medical Sciences, Little Rock, USA
Brandon J. Griffin PhD

Clinical Neurosciences Division, National Center for PTSD, West Haven, USA
Robert H. Pietrzak PhD

Department of Psychiatry, Yale School of Medicine, New Haven, USA
Robert H. Pietrzak PhD

Dissemination and Training Division, National Center for PTSD, Menlo Park, USA
Carmen P. McLean PhD

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, USA
Carmen P. McLean PhD

Psychiatry Department, Geisel School of Medicine at Dartmouth, Lebanon, USA
Jessica L. Hamblen PhD

Executive Division, National Center for PTSD, White River Junction, USA
Jessica L. Hamblen PhD & Sonya B. Norman PhD

Psychiatry Department, University of California San Diego School of Medicine, La Jolla, USA
Sonya B. Norman PhD

Share